The New Health Care: Why the Price of Sovaldi Is a Shock to the System

Wednesday, August 6, 2014 - 11:30 in Mathematics & Economics

The drug for hepatitis C has the popularity of a mass-market drug but the price of a specialty drug, adding up to huge costs that are worrying insurers.

Read the whole article on NY Times Health

More from NY Times Health

Learn more about

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net